Trial Profile
Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Exploratory Pharmacodynamics of LIM-0705 Given With or Without Tacrolimus in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs LIM 0705 (Primary) ; Tacrolimus
- Indications Transplant rejection
- Focus Adverse reactions
- Sponsors Limerick BioPharma
- 05 May 2014 New trial record